Nanologica AB (publ) (STO:NICA)

Nanologica AB Statistics

Total Valuation

Nanologica AB has a market cap or net worth of SEK 163.93 million. The enterprise value is 187.15 million.

Market Cap	163.93M
Enterprise Value	187.15M

Important Dates

The last earnings date was Thursday, July 10, 2025.

Earnings Date	Jul 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Nanologica AB has 88.37 million shares outstanding. The number of shares has increased by 78.45% in one year.

Current Share Class	88.37M
Shares Outstanding	88.37M
Shares Change (YoY)	+78.45%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	10.95%
Owned by Institutions (%)	17.52%
Float	32.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.03
PB Ratio	3.18
P/TBV Ratio	3.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.11
EV / Sales	9.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.76

Financial Position

The company has a current ratio of 5.00, with a Debt / Equity ratio of 0.96.

Current Ratio	5.00
Quick Ratio	1.51
Debt / Equity	0.96
Debt / EBITDA	n/a
Debt / FCF	-0.73
Interest Coverage	-8.75

Financial Efficiency

Return on equity (ROE) is -182.34% and return on invested capital (ROIC) is -37.33%.

Return on Equity (ROE)	-182.34%
Return on Assets (ROA)	-30.29%
Return on Invested Capital (ROIC)	-37.33%
Return on Capital Employed (ROCE)	-55.99%
Revenue Per Employee	1.13M
Profits Per Employee	-3.35M
Employee Count	16
Asset Turnover	0.19
Inventory Turnover	0.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.46% in the last 52 weeks. The beta is 0.36, so Nanologica AB's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-67.46%
50-Day Moving Average	1.24
200-Day Moving Average	1.64
Relative Strength Index (RSI)	74.21
Average Volume (20 Days)	163,792

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nanologica AB had revenue of SEK 20.41 million and -60.22 million in losses. Loss per share was -0.87.

Revenue	20.41M
Gross Profit	2.03M
Operating Income	-53.03M
Pretax Income	-60.22M
Net Income	-60.22M
EBITDA	-51.83M
EBIT	-53.03M
Loss Per Share	-0.87

Balance Sheet

The company has 26.38 million in cash and 49.60 million in debt, giving a net cash position of -23.22 million or -0.26 per share.

Cash & Cash Equivalents	26.38M
Total Debt	49.60M
Net Cash	-23.22M
Net Cash Per Share	-0.26
Equity (Book Value)	51.59M
Book Value Per Share	0.58
Working Capital	71.50M

Cash Flow

In the last 12 months, operating cash flow was -67.84 million and capital expenditures -8,000, giving a free cash flow of -67.85 million.

Operating Cash Flow	-67.84M
Capital Expenditures	-8,000
Free Cash Flow	-67.85M
FCF Per Share	-0.77

Margins

Gross margin is 9.93%, with operating and profit margins of -259.79% and -294.98%.

Gross Margin	9.93%
Operating Margin	-259.79%
Pretax Margin	-294.98%
Profit Margin	-294.98%
EBITDA Margin	-253.87%
EBIT Margin	-259.79%
FCF Margin	n/a

Dividends & Yields

Nanologica AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-78.45%
Shareholder Yield	n/a
Earnings Yield	-36.73%
FCF Yield	-41.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanologica AB has an Altman Z-Score of -4.03 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.03
Piotroski F-Score	3